Clinical Trials on Acne Vulgaris in Ireland

Total 34 results

Bausch Health Americas, Inc.

Completed

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Thesan Pharmaceuticals, Inc.

Withdrawn

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Dominican Republic, Honduras
Actavis Inc.

Completed

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Belize
Gage Development Company, LLC

Completed

Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Canada
Bausch Health Americas, Inc.

Completed

A Study of Acne Treatment in Children Ages 9 to 11

Acne Vulgaris

United States
Braintree Laboratories

Completed

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Photocure

Completed

A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris

Acne Vulgaris

United States
Mimetica Pty Limited

Unknown

A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Bayer

Completed

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Acne Vulgaris

United States
Vyne Therapeutics Inc.

Completed

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Acne Vulgaris

United States, Dominican Republic
Botanix Pharmaceuticals

Completed

Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States, Australia
Bausch Health Americas, Inc.

Completed

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Acne Vulgaris

United States, Canada
Intrepid Therapeutics, Inc.

Completed

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

Acne Vulgaris

United States
Vyne Therapeutics Inc.

Completed

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

Acne Vulgaris

United States, Canada
Bausch Health Americas, Inc.

Completed

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

Acne Vulgaris

United States, Canada
Dermira, Inc.

Completed

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Almirall, S.A.
Allergan

Completed

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Cassiopea SpA

Completed

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

Acne Vulgaris

United States, Bulgaria, Romania, Serbia, Georgia, Poland, Ukraine
Braintree Laboratories

Completed

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Vyne Therapeutics Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

Acne Vulgaris

United States
Dermira, Inc.

Completed

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Acne Vulgaris

United States, Canada
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

Acne Vulgaris

United States, Bulgaria, Georgia, Poland, Romania, Serbia
Cassiopea SpA

Completed

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

Acne Vulgaris

United States, Georgia, Ukraine
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Acne Vulgaris

United States
St. James's Hospital, Ireland
University of Dublin, Trinity College; Science Foundation Ireland

Recruiting

The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders (NEUTROPRO)

Atopic Dermatitis | Psoriasis Vulgaris | Ichthyosis Vulgaris

Ireland
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

Psoriasis Vulgaris

Ireland, Germany, United Kingdom, Canada, Sweden
LEO Pharma

Completed

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

Psoriasis Vulgaris

United States, Canada, United Kingdom, Germany, Romania, France, Poland
Pfizer

Completed

Tofacitinib Ointment For Chronic Plaque Psoriasis

Psoriasis | Psoriasis Vulgaris

United States, Canada, Denmark, Poland
ChemoCentryx

Completed

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

Hidradenitis Suppurativa | Acne Inversa

United States
Shire

Terminated

Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

ACE Inhibitor Induced Angioedema

United States

3

Subscribe